Illumina unveils first-of-its-kind spatial transcriptomics technology

Broad Institute to collaborate on flagship project tapping Illumina's new spatial technologyAt AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning pulmonary fibrosis, prostate cancer, and 3D reconstructions of mouse brainsCompany expands software portfolio to decode multimodal data with Illumina Connected MultiomicsSAN DIEGO, Feb. 19, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced a new spatial technology program that will empower resea ...